Aurora Cannabis products unavailable in Germany until further notice
Aurora Cannabis’ medical marijuana products are temporarily unavailable in Germany pending a review by health authorities of “a…
News November 29
Latest In: Europe
What businesses need to know about exporting irradiated medical cannabis to Germany
By now, everyone knows that to export medical cannabis to Germany, which is by far the largest importer…
News November 27
Cyprus delays bidding process so medical cannabis licensing fees can be reviewed
The bidding process to cultivate medical cannabis in Cyprus is stalled after government authorities requested a review of…
News November 26
Early talks underway on future of Denmark’s medical cannabis pilot program
The Danish government is engaging stakeholders about the future of the country’s medical cannabis pilot program, but industry…
News November 25
Germany reveals wholesale medical cannabis price at 2.3 euros per gram, signaling no windfall for suppliers
The German federal government will buy at least 650 kilograms (1,433 pounds) of medical cannabis flower from domestic…
News November 22
Australian-grown medical cannabis clears key export hurdle for first time
Australia is one step closer to joining Canada and the Netherlands in the competitive medical cannabis export market.
News November 19
Tips for entering Europe’s medical cannabis market: Q&A with Christian Carlsen of Danish pharma firm NNE
Could medical cannabis be a growth engine for the pharmaceutical industry? A subsidiary of Danish pharmaceutical giant Novo Nordisk…
News November 19
England’s health insurance has covered only 18 ‘unlicensed’ cannabis prescriptions
Since a new law took effect a year ago, England’s National Health Service (NHS) has reimbursed patients on only 18 occasions…
News November 19
Proposed law in North Macedonia to allow cannabis flower export shelved
A North Macedonian draft bill that proposed modifications to the current medical cannabis framework has been removed from parliament’s…
News November 13
New UK guidelines recommend public insurance coverage for two GW Pharma cannabis medicines, plus a synthetic cannabinoid
New British guidelines for the first time recommend that two plant-based cannabis medicines – Sativex and Epidiolex –…
News November 12
Latest Sponsored
